Profession Notes

Flush with an $80 million gift from an anonymous donor, three New York institutions are creating a joint biology program emphasizing chemistry, computation, and cancer. The institutions, which together will contribute another $80 million, are Cornell University (including its Weill Medical College), Memorial Sloan-Kettering Cancer Center (MSKCC), and Rockefeller University. Officials announced the Tri-Institutional Research Program announced on June 27 at a ceremony capped by a kiss between brot

Written byDouglas Steinberg
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Flush with an $80 million gift from an anonymous donor, three New York institutions are creating a joint biology program emphasizing chemistry, computation, and cancer. The institutions, which together will contribute another $80 million, are Cornell University (including its Weill Medical College), Memorial Sloan-Kettering Cancer Center (MSKCC), and Rockefeller University. Officials announced the Tri-Institutional Research Program announced on June 27 at a ceremony capped by a kiss between brothers David and Laurance Rockefeller, honorary chairmen of the boards of Rockefeller University and MSKCC, respectively. Presidents of the three institutions also spoke. Cornell's Hunter Rawlings described its Ithaca campus as offering "an ideal facility for obtaining atom-by-atom pictures of biological molecules." Noting that "we are very different kinds of institutions," MSKCC's Harold Varmus said that the joint program would have "all the components required to exploit new developments in biology." And Rockefeller's Arnold Levine predicted, "This is the beginning of what ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies